Tri Locum Partners LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001826434

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2023 · 61 positions · Total reported value $312.76M · Top-10 concentration 58.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 90.9% · 3 new · 13 cut · 4 exited

Active Share (vs S&P 500): 97.4% · vs QQQ: 99.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.6% · vs SPY -3.7% · Prev Value $813.22M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +2.1% · vs SPY -0.0% · Latest Value $506.14M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, Tri Locum Partners LP disclosed 61 equity positions with a combined reported value of $312.76M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were AMGN ($28.89M), TEVA ($26.86M), DXCM ($24.95M). By sector, the heaviest allocations are Health Care 72.8%, Consumer Discretionary 0.5%.

Versus the prior quarter, Tri Locum Partners LP opened 3 new positions, trimmed 13 and fully exited 4, a turnover rate of 90.9% of positions.

The largest new positions opened in Q3 2023 were AMGN ($28.89M), TEVA ($26.86M), DXCM ($24.95M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • AMGN AMGEN INC · $28.89M
  • TEVA TEVA PHARMACEUTICAL INDS LTD · $26.86M
  • DXCM DEXCOM INC · $24.95M
  • ABBV ABBVIE INC · $21.55M
  • SPY STATE STR SPDR S&P 500 ETF T · $19.33M
  • REGN REGENERON PHARMACEUTICALS · $16.47M
  • CTLT CATALENT INC · $13.02M
  • NTRA NATERA INC · $12.16M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Tri Locum Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Tri Locum Partners LP, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 19 positions worth $813.22M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-119074 (status: Approved), registered 2020-07-16
  • Regulatory AUM (Form ADV): $1.09B as of 2026-04-06
  • Client mix (by RAUM): pension and profit-sharing plans 64%, sovereign wealth funds 36%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 19 positions · $813.22M reported value (Q2 2026)
  • Top 10 holdings = 80.0% of reported value
  • Largest position: JNJ (JOHNSON & JOHNSON) at 13.3%
  • Average position size: $42.80M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 9 added, 6 reduced, 2 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 72.8%
Financials 0.2%
Technology 0.1%
Other 26.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 107.48K $28.89M 9.24%
9.24%
New
2 2.63M $26.86M 8.59%
8.59%
New
3 267.38K $24.95M 7.98%
7.98%
New
4 144.56K $21.55M 6.89%
6.89%
New
5 45.21K $19.33M 6.18%
6.18%
New
6 20.01K $16.47M 5.26%
5.26%
New
7 286.00K $13.02M 4.16%
4.16%
New
8 274.80K $12.16M 3.89%
3.89%
New
9 983.60K $10.13M 3.24%
3.24%
New
10 142.51K $9.96M 3.19%
3.19%
New
11 131.81K $8.97M 2.87%
2.87%
New
12 22.45K $8.42M 2.69%
2.69%
New
13 4.86M $8.30M 2.65%
2.65%
New
14 536.39K $8.04M 2.57%
2.57%
New
15 14.35K $7.05M 2.25%
2.25%
New
16 6.25M $6.81M 2.18%
2.18%
New
17 369.91K $5.87M 1.88%
1.88%
New
18 171.75K $5.87M 1.88%
1.88%
New
19 208.89K $5.34M 1.71%
1.71%
New
20 113.53K $5.22M 1.67%
1.67%
New
21 318.08K $5.18M 1.66%
1.66%
New
22 282.86K $5.18M 1.66%
1.66%
New
23 821.38K $5.04M 1.61%
1.61%
New
24 33.76K $4.93M 1.58%
1.58%
New
25 598.13K $4.46M 1.43%
1.43%
New
26 56.23K $4.23M 1.35%
1.35%
New
27 249.57K $3.85M 1.23%
1.23%
New
28 314.03K $3.60M 1.15%
1.15%
New
29 304.97K $3.53M 1.13%
1.13%
New
30 53.30K $3.04M 0.97%
0.97%
New
31 44.23K $3.00M 0.96%
0.96%
New
32 8.35K $2.44M 0.78%
0.78%
New
33 251.70K $2.25M 0.72%
0.72%
New
34 155.57K $1.58M 0.51%
0.51%
New
35 55.00K $1.10M 0.35%
0.35%
New
36 36.61K $838.64K 0.27%
0.27%
New
37 381.08K $807.89K 0.26%
0.26%
New
38 43.44K $595.53K 0.19%
0.19%
New
39 3.50K $248.19K 0.08%
0.08%
New
40 568 $247.32K 0.08%
0.08%
New
41 8.32K $235.09K 0.07%
0.07%
New
42 76.61K $228.28K 0.07%
0.07%
New
43 1.42K $221.80K 0.07%
0.07%
New
44 1.75K $218.77K 0.07%
0.07%
New
45 2.58K $216.86K 0.07%
0.07%
New
46 932 $214.65K 0.07%
0.07%
New
47 1.73K $213.95K 0.07%
0.07%
New
48 1.02K $204.08K 0.07%
0.07%
New
49 3.66K $200.20K 0.06%
0.06%
New
50 10.21K $187.55K 0.06%
0.06%
New

FAQ

What did Tri Locum Partners LP buy in 2023-Q3?

In its 2023-Q3 13F filing, Tri Locum Partners LP reported 61 equity positions worth $312.76M in aggregate; its largest disclosed positions were AMGN ($28.89M), TEVA ($26.86M), DXCM ($24.95M).

How large is Tri Locum Partners LP's portfolio?

Tri Locum Partners LP reported $312.76M of long equity holdings across 61 positions as of 2023-Q3. Top-10 holdings account for 58.6% of reported value.

What is Tri Locum Partners LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tri-locum-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →